February 5, 2015—The Health Resources and Services Administration today identified 13 drug companies that are not complying with its 340B orphan drug exclusion interpretive rule.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)